At least $200 million will be invested in start-up companies under the latest tranche of the federal government’s Innovation Investment Fund. [ + ]

Phosphagenics (ASX:POH) and Japan’s Nippon Zoki have progressed to the negotiation stage in their tie-up to produce an anti-inflammation product for the US market. [ + ]

The class of HER2/neu breast cancer vaccines to which Biolife Science’s HER-Vaxx belongs has been endorsed in a key breast cancer journal. [ + ]

pSivida licensee Alimera Sciences has made a resubmission to the US Food and Drug Administration for approval of Iluvien for chronic diabetic macular edema. [ + ]

Calzada’s (ASX:CZD) PolyNovo unit has wrapped up a human trial involving using NovoSorb in vacuum-assisted closure of pressure sores. [ + ]

AusBiotech’s March industry submission addresses the Therapeutic Goods Administration’s (TGA) proposed changes to the pre-market assessment requirements for medical devices. [ + ]

A new diagnostic test that uses a scientific technique known as metabolomic analysis may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection. [ + ]

New research has identified more than 80 genetic variations that can increase a person’s risk of prostate, breast and ovarian cancers. [ + ]

Rice University researchers have found an unexpected link between a protein that triggers the formation of blood clots and other proteins that are essential for the body’s immune system. The find could lead to new treatments for thousands of patients who suffer from inflammatory diseases and disorders that cause abnormal blood clotting. [ + ]

Bioniche (ASX:BNC) is back in control of commercialisation activities for bladder cancer treatment Urocidin after wrapping up its partnership with Endo Pharmaceuticals. [ + ]

Bioniche (ASX:BNO) has lauded decisions by the Canadian government to provide more funding for programs which support R&D and commercialisation efforts by the nation’s companies. [ + ]

WR Grace & Co has filed a lawsuit in the US District Court for the District of Delaware against Teledyne Technologies for infringement of four Grace US patents that cover its proprietary Reveleris X2 flash chromatography system. [ + ]

AusBiotech is pleased to provide the latest edition of the Australasian Biotechnology e-journal (Volume 23, Number 1). [ + ]

Professor Suzanne Cory is the first Australian to be admitted to the Japanese Academy of Science. [ + ]

The Australian Science Media Centre is delighted to announce Dr Alan Finkel as the organisation’s Australian patron. [ + ]